Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. META
5. SPY
6. ACN
7. IBM
8. PRIM
9. PFE
10. TSLA

Go back to Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2

Cantor Fitzgerald Reiterates Overweight Rating on Pfizer (PFE)

July 23, 2020 7:01 AM EDT

Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $53.00 price target on Pfizer (NYSE: PFE) after speaking with a KOL about the company's hemophilia franchise. The doctor said that conventional thinking is that gene therapy will last 5-10 years, but... More